文献速递慢性静脉疾病

导管导向泡沫硬化剂联合肿胀麻醉治疗大隐静脉功能不全的中期结果

Mid-term Results of Catheter Directed Foam Sclerotherapy Combined with Tumescent Local Anaesthesia for Treatment of Great Saphenous Vein Incompetence.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-06-29

这项前瞻性研究纳入249例单侧大隐静脉功能不全患者,评估单次导管导向泡沫硬化剂(CDFS)联合肿胀局部麻醉(TLA)治疗3年后的闭塞率、临床严重程度、生活质量及安全性。3年时膝上大隐静脉持续闭塞的累积比例为81.5%,无膝上大隐静脉反流者为89.6%,VCSS与CIVIQ评分均显著改善,无严重不良事件。

要点

  • CDFS联合TLA治疗大隐静脉功能不全3年累积闭塞率达81.5%。
  • 89.6%患者3年时无膝上大隐静脉反流,VCSS与CIVIQ显著改善。
  • 无严重不良事件,血栓性静脉炎、色素沉着/毛细血管扩张、一过性暗点发生率低。

核心结论

  • CDFS联合TLA治疗大隐静脉功能不全在闭塞率、临床严重程度、生活质量及安全性方面取得良好的中期结果。

研究设计与样本

  • 前瞻性研究纳入249例有症状的单侧大隐静脉功能不全患者,接受CDFS联合TLA并随访3年。
  • 主要结局为治疗段大隐静脉完全闭塞,次要结局包括VCSS、CIVIQ评分变化、无膝上大隐静脉反流及安全性。

主要发现

  • 3年后膝上大隐静脉持续闭塞的估计累积比例为81.5%。
  • 89.6%的患者无膝上大隐静脉反流。
  • VCSS和CIVIQ评分均显著改善(p < .0001和<.0001)。
  • 无严重不良事件;血栓性静脉炎、皮肤色素沉着/毛细血管扩张、一过性暗点分别见于2%、7.8%、0.8%的病例。

临床怎么用

  • 对于有症状的大隐静脉功能不全患者,可考虑单次CDFS联合TLA作为治疗选择,中期闭塞率与安全性良好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The purpose of this prospective study was to evaluate the occlusion rate, clinical severity, disease specific health related quality of life (HRQoL), and safety in patients with great saphenous vein (GSV) reflux 3 years after a single treatment session of catheter directed foam sclerotherapy (CDFS) combined with peri-saphenous infiltration of tumescent local anaesthesia (TLA). METHODS: A total of 249 patients with symptomatic unilateral GSV incompetence underwent CDFS combined with TLA and were followed up for 3 years. The primary outcome was complete obliteration of the treated segment of the GSV. Secondary outcomes were changes in Venous Clinical Severity Score (VCSS) and Chronic Venous Insufficiency Quality of Life Questionnaire (CIVIQ) score, absence of above knee GSV reflux, and safety of treatment. RESULTS: Three years after CDFS, the estimated cumulative proportion of persistently obliterated above knee GSV was 81.5%. Freedom from above knee GSV reflux was demonstrated in 89.6% of patients. Both the VCSS and CIVIQ score improved significantly (p < .0001 and <.0001, respectively). No major adverse events were encountered. Thrombophlebitis, skin pigmentation/matting, and transient scotomata were reported in 2%, 7.8%, and 0.8% of cases, respectively. CONCLUSION: CDFS combined with TLA for treatment of GSV incompetence yields good mid-term results in terms of occlusion rate, clinical severity, patients' QoL, and safety.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ali H, Elbadawy A, Saleh M, et al. Mid-term Results of Catheter Directed Foam Sclerotherapy Combined with Tumescent Local Anaesthesia for Treatment of Great Saphenous Vein Incompetence. Eur J Vasc Endovasc Surg. 2017. PMID: 28669458. doi:10.1016/j.ejvs.2017.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。